Added to YB: 2024-12-18
Pitch date: 2024-12-18
LQDA:US [bullish]
Liquidia Corporation
+630.16%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.
Market Cap
$6.0B
Pitch Price
$10.81
Price Target
N/A
Dividend
N/A
EV/EBITDA
125.43
P/E
278.59
EV/Sales
20.86
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Liquidia Corporation LQDA:US
A summary for this pitch has not been created yet.
Read full article (0 min)